Risultati della ricerca - Ludwig Kappos

Raffina i risultati
  1. 1
    Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis

    Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis di Ludwig Kappos

    Pubblicazione 1998
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions

    Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions di Matthias Mehling, Ludwig Kappos, Tobias Derfuß

    Pubblicazione 2011
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Black holes in multiple sclerosis: definition, evolution, and clinical correlations

    Black holes in multiple sclerosis: definition, evolution, and clinical correlations di Mohammad Ali Sahraian, Ernst W. Radue, Sven Haller, Ludwig Kappos

    Pubblicazione 2009
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  4. 4
    Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results

    Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results di Jeffrey A. Cohen, Nadia Tenenbaum, Alit Bhatt, Ying Zhang, Ludwig Kappos

    Pubblicazione 2019
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review)

    Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review) di DS Goodin, Bruce A. Cohen, Paul O’Connor, Ludwig Kappos, J. Clarke Stevens

    Pubblicazione 2008
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  6. 6
    Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum

    Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum di Yvonne Naegelin, Hayley Dingsdale, Katharina Säuberli, Sabine Schädelin, Ludwig Kappos, Yves‐Alain Barde

    Pubblicazione 2018
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and Perspective

    Wearable Sensor Technologies to Assess Motor Functions in People With Multiple Sclerosis: Systematic Scoping Review and Perspective di Tim Woelfle, Lucie Bourguignon, Johannes Lorscheider, Ludwig Kappos, Yvonne Naegelin, Catherine R. Jutzeler

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

    Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines. di David H. Miller, Frederik Barkhof, I. Berry, Ludwig Kappos, Giuseppe Scotti, Alan J. Thompson

    Pubblicazione 1991
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood-brain barrier leakage correction

    Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood-brain barrier leakage correction di Reta Haselhorst, Ludwig Kappos, Deniz Bilecen, Klaus Scheffler, David M�ri, E. W. Rad�, Joachim Seelig

    Pubblicazione 2000
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

    Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis di Gıancarlo Comı, Douglas Jeffery, Ludwig Kappos, Xavier Montalbán, Alexey Boyко, Maria A. Rocca, Massimo Filippi

    Pubblicazione 2012
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis

    Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis di Goeril Karlsson, Gordon Francis, Gideon Koren, Peter Heining, Xiaoli Zhang, Jeffrey A. Cohen, Ludwig Kappos, William Collins

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4<sup>+</sup>T Cells of Patients with Relapsing-Remitting Multiple Sclerosis

    Unraveling Natalizumab Effects on Deregulated miR-17 Expression in CD4<sup>+</sup>T Cells of Patients with Relapsing-Remitting Multiple Sclerosis di Maria Meira, Claudia Sievers, Francine Hoffmann, Maria Rasenack, Jens Kühle, Tobias Derfuß, Ludwig Kappos, Raija L.P. Lindberg

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Computer assisted retraining of attentional impairments in patients with multiple sclerosis

    Computer assisted retraining of attentional impairments in patients with multiple sclerosis di Andrea M. Plohmann, Ludwig Kappos, W Ammann, A Thordai, Aymric Wittwer, S. J. Huber, Y Bellaiche, Jeannette Lechner‐Scott

    Pubblicazione 1998
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Clinical effects of natalizumab on multiple sclerosis appear early in treatment course

    Clinical effects of natalizumab on multiple sclerosis appear early in treatment course di Ludwig Kappos, Paul O’Connor, Christopher H. Polman, Patrick Vermersch, Heinz Wiendl, Amy Pace, Annie Zhang, Christophe Hotermans

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results

    Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results di Helmut Butzkueven, Ludwig Kappos, Fabio Pellegrini, María Trojano, Heinz Wiendl, Ruchi Patel, A. Zhang, Christophe Hotermans, Shibeshih Belachew

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    MS quality of life, depression, and fatigue improve after mindfulness training

    MS quality of life, depression, and fatigue improve after mindfulness training di Paul Grossman, Ludwig Kappos, Henrik Gensicke, Melba Sheila D’Souza, David C. Mohr, Iris‐Katharina Penner, C Steiner

    Pubblicazione 2010
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  17. 17
    Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.

    Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. di A Valli, Alessandro Sette, Ludwig Kappos, Carla Oseroff, John Sidney, G Miescher, Martina Hochberger, Eliseo Albert, Luciano Adorini

    Pubblicazione 1993
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM studies

    Effect of delayed-release dimethyl fumarate on no evidence of disease activity in relapsing-remitting multiple sclerosis: integrated analysis of the phase III DEFINE and CONFIRM st... di Eva Havrdová, Gavin Giovannoni, Ralf Gold, Robert Fox, Ludwig Kappos, J. Theodore Phillips, Macaulay Okwuokenye, Jing L. Marantz

    Pubblicazione 2017
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

    Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis di Nelly Siller, Jens Kühle, Muthuraman Muthuraman, Christian Barro, Timo Uphaus, Sergiu Groppa, Ludwig Kappos, Frauke Zipp, Stefan Bittner

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE

    Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE di Ralf Gold, Douglas L. Arnold, Amit Bar‐Or, Robert J. Fox, Ludwig Kappos, Chongshu Chen, Becky Parks, Catherine Miller

    Pubblicazione 2020
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: